Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
57.05
-0.06 (-0.11%)
Nov 8, 2024, 4:00 PM EST - Market closed

Soleno Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-131.16-38.99-24.07-30.91-24.64-30.77
Upgrade
Depreciation & Amortization
1.971.961.961.961.951.96
Upgrade
Stock-Based Compensation
72.115.952.533.281.50.83
Upgrade
Other Operating Activities
3.843.22-0.45-0.95-7.017.64
Upgrade
Change in Accounts Payable
3.131.37-1.48-0.241.491.06
Upgrade
Change in Other Net Operating Assets
2.191.560.72-0.911.481.44
Upgrade
Operating Cash Flow
-51.42-24.94-20.78-27.77-25.22-17.38
Upgrade
Capital Expenditures
-0.21--0.01-0.02-0.01-0.02
Upgrade
Investment in Securities
-231.92----0.5
Upgrade
Other Investing Activities
-----0.05
Upgrade
Investing Cash Flow
-232.13--0.01-0.02-0.010.53
Upgrade
Long-Term Debt Repaid
----0.01-0.02-0
Upgrade
Total Debt Repaid
----0.01-0.02-0
Upgrade
Net Debt Issued (Repaid)
----0.01-0.02-0
Upgrade
Issuance of Common Stock
279.52180.0214.11-53.7414.48
Upgrade
Repurchase of Common Stock
---0.02-0.12--
Upgrade
Financing Cash Flow
279.52180.0214.09-0.1353.7214.48
Upgrade
Net Cash Flow
-4.02155.08-6.7-27.9228.49-2.37
Upgrade
Free Cash Flow
-51.63-24.94-20.79-27.79-25.23-17.4
Upgrade
Free Cash Flow Per Share
-1.36-1.51-2.48-5.23-6.04-7.64
Upgrade
Levered Free Cash Flow
-93.26-12.82-11.71-15.79-13.3-8.79
Upgrade
Unlevered Free Cash Flow
-93.26-12.82-11.71-15.79-13.3-8.79
Upgrade
Change in Net Working Capital
14.42-3.440.490.85-3.22-2.95
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.